Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
Kimura K, Tsukamoto S, Miyazaki K, Kawajiri-Manako C, Ishii A, Rahmutulla B, Fukuyo M, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Ohwada C, Iseki T, Matsusaka K, Sanada M, Yokote K, Kaneda A, Ishida T, Suzuki K, Nakaseko C, Sakaida E. Kimura K, et al. Exp Hematol. 2021 Sep;101-102:34-41.e4. doi: 10.1016/j.exphem.2021.08.001. Epub 2021 Aug 17. Exp Hematol. 2021. PMID: 34411686 Free article.
[Severe stomatitis and ileocecal perforation developed after all-trans retinoic acid monotherapy in an HLA-B51-positive patient with acute promyelocytic leukemia].
Kimura K, Takeuchi M, Hasegawa N, Togasaki E, Shimizu R, Kawajiri C, Muto T, Tsukamoto S, Takeda Y, Ohwada C, Sakaida E, Sakai S, Mimura N, Ota S, Iseki T, Nakaseko C. Kimura K, et al. Rinsho Ketsueki. 2016 Jun;57(6):765-70. doi: 10.11406/rinketsu.57.765. Rinsho Ketsueki. 2016. PMID: 27384858 Review. Japanese.
Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan.
Noguchi S, Nakaseko C, Nishiwaki K, Ogasawara H, Ohishi K, Tokuhira M, Noguchi M, Kimura H, Handa H, Mitani K, Miura M, Wakita H, Takahashi N; STAT study group. Noguchi S, et al. Among authors: kimura h. Int J Hematol. 2018 Aug;108(2):176-183. doi: 10.1007/s12185-018-2459-6. Epub 2018 Apr 30. Int J Hematol. 2018. PMID: 29713954 Clinical Trial.
[MALT lymphoma accompanied by elevated serum IgM levels mimicking Waldenström's macroglobulinemia].
Izumi S, Kimura K, Takeda Y, Tsukamoto S, Yamazaki M, Mishina T, Nagai Y, Takaishi K, Nagao Y, Oshima-Hasegawa N, Mitsukawa S, Mimura N, Takeuchi M, Ohwada C, Iseki T, Ota S, Nakaseko C, Sakaida E. Izumi S, et al. Among authors: kimura k. Rinsho Ketsueki. 2018;59(12):2600-2605. doi: 10.11406/rinketsu.59.2600. Rinsho Ketsueki. 2018. PMID: 30626796 Japanese.
Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis.
Takaishi K, Tsukamoto S, Ohwada C, Takeuchi M, Kawasaki Y, Nagai Y, Mishina T, Yamazaki M, Isshiki Y, Kayamori K, Kimura K, Hino Y, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Iseki T, Nakaseko C, Sakaida E. Takaishi K, et al. Among authors: kimura k. J Thromb Thrombolysis. 2019 Jul;48(1):141-148. doi: 10.1007/s11239-019-01809-w. J Thromb Thrombolysis. 2019. PMID: 30673940
Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells.
Takaishi K, Takeuchi M, Tsukamoto S, Takayama N, Oshima M, Kimura K, Isshiki Y, Kayamori K, Hino Y, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Iseki T, Nakamura S, Eto K, Iwama A, Yokote K, Nakaseko C, Sakaida E. Takaishi K, et al. Among authors: kimura k. Haematologica. 2020 May;105(5):e216-e220. doi: 10.3324/haematol.2018.214841. Epub 2019 Sep 5. Haematologica. 2020. PMID: 31488559 Free PMC article. No abstract available.
7,150 results